ACE and type 2 diabetes mellitus: In 1435 type 2 diabetic patients with nephropathy, who participated to the RENAAL study, the ACE D allele was associated with poor renal prognosis in the placebo group, whereas no such association was found in the losartan group, which suggests that losartan was able to correct the poor prognosis associated with the ACE D allele [262].